Feasibility of Whole-body Drumming Classes for People With Parkinson's Disease

Parkinson Disease Clinical Trial

Official title:

Feasibility and Effects of Whole-body Drumming Classes on Walking in People With Parkinson's Disease: a Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04982003
• Other study ID #: 2019-004
• Status: Completed
• Phase: N/A
• Start date: February 22, 2019
• Est. completion date: July 30, 2022

Study information

• Verified date: January 2023
• Source: A.T. Still University of Health Sciences
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

People with Parkinson's disease (PD) experience difficulty with gait, postural instability, and lack of movement coordination and rhythmic timing. Non-motor functions affected by PD include time perception, feelings of apathy, depression, decreased self-efficacy, and decrease self-reported quality of life. There is currently a lack of information on how a therapeutic drumming class that uses whole-body large-amplitude movements to music would impact these motor and non-motor impairments in individuals with PD. The primary purpose of this study is to assess the feasibility of a 10-week whole-body drumming class to music specifically selected for its rhythmic structure, and effects on movement rhythm and time perception in individuals with PD. The secondary purpose is to assess the effects of the drumming class on apathy, depression, self-efficacy and health-related quality of life. Participants will be included if they have a diagnosis of PD and are able to move for an hour with rests, either standing or seated. Participants are tested before and after the class series and one month following.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 38
• Est. completion date: July 30, 2022
• Est. primary completion date: July 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• diagnosed with PD

• independent walking short community and household distances with or without assistive device

• able to participate in a 1-hour class once a week for ten weeks

Exclusion Criteria:

• change of Parkinson's medication or deep brain stimulation parameters within 2 weeks prior to or during the study

• inability to grasp 2-inch diameter "drum sticks"

• any conditions with contraindications to lift upper extremities overhead

• any medical restrictions to exercise

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Other:
• exercise
10 weekly hour-long classes of drumming to music using large-amplitude, whole-body movements

Locations

Country	Name	City	State
United States	A.T. Still University Arizona School of Health Sciences	Mesa	Arizona

Sponsors (1)

Lead Sponsor	Collaborator
A.T. Still University of Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Step Cadence Variability	Variability (SD) of step cadence	within 7 days before the intervention
Primary	Step Cadence Variability	Variability (SD) of step cadence	within 7 days after intervention
Primary	Step Cadence Variability	Variability (SD) of step cadence	1-month following intervention
Primary	Stride Length Variability	Variability (SD) of stride length	within 7 days before the intervention
Primary	Stride Length Variability	Variability (SD) of stride length	within 7 days after intervention
Primary	Stride Length Variability	Variability (SD) of stride length	1-month following intervention
Primary	Change in repeated finger-tapping	change in inter-tapping intervals (ms) change from pre- to post-intervention	within 7 days before the intervention and within 7 days after intervention
Primary	Change in repeated finger-tapping	change in inter-tapping intervals (ms) change from pre- to 1-month following end of intervention	within 7 days before the intervention and 1-month following end of intervention
Secondary	Change in Nine-hole peg test (NHP) duration (s)	change in speed of manual dexterity (s on NHP) from pre- to post-intervention	within 7 days before the intervention and within 7 days after intervention
Secondary	Change in Nine-hole peg test (NHP) duration (s)	change in speed of manual dexterity (s on NHP) from pre- to 1-month following end of intervention	within 7 days before the intervention, and 1-month following intervention
Secondary	Change in Physical Performance Test (PPT) score	change in whole-body functional mobility (PPT score; 0-36; higher is better) from pre- to post-intervention.	within 7 days before the intervention and within 7 days after intervention
Secondary	Change in Physical Performance Test (PPT) score	change in whole-body functional mobility (PPT score; 0-36; higher is better) from pre- to 1-month following end of intervention	within 7 days before the intervention, and 1-month following intervention
Secondary	Change in Parkinson Disease Questionnaire (PDQ-39)	change in disease-related quality of life (PDQ-39 score; 0-100, lower is better with improved quality of life) from pre- to post-intervention	within 7 days before the intervention and within 7 days after intervention
Secondary	Change in Parkinson Disease Questionnaire (PDQ-39)	change in disease-related quality of life (PDQ-39 score; 0-100, lower is better with improved quality of life) from pre- to 1-month following end of intervention	within 7 days before the intervention, and 1-month following intervention
Secondary	Geriatric Depression Scale (GDS)	change in depression (GDS score; 0-15, higher is worse with more depression) from pre- to post-intervention	within 7 days before the intervention and within 7 days after intervention
Secondary	Geriatric Depression Scale (GDS)	change in depression (GDS score; 0-15, higher is worse with more depression) from pre- to 1-month following end of intervention	within 7 days before the intervention, and 1-month following intervention
Secondary	General Self-Efficacy scale (GSE)	change in self-efficacy (GSE score; 10-40, higher is better with more self-efficacy) from pre- to post-intervention	within 7 days before the intervention and within 7 days after intervention
Secondary	General Self-Efficacy scale (GSE)	change in self-efficacy (GSE score; 10-40, higher is better with more self-efficacy) from pre- to 1-month following end of intervention	within 7 days before the intervention, and 1-month following intervention
Secondary	Lille Apathy Rating Scale (LARS)	change in apathy (LARS score; -36 to +36, lower is better with less apathy) from pre- to post-intervention	within 7 days before the intervention and within 7 days after intervention
Secondary	Lille Apathy Rating Scale (LARS)	change in apathy (LARS score; -36 to +36, lower is better with less apathy) from pre- to 1-month following end of intervention	within 7 days before the intervention, and 1-month following intervention